+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships - Product Thumbnail Image

Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships

  • Report
  • August 2021
  • 91 Pages
  • Global
From
Bevacizumab Biosimilar Market Opportunity, Sales, Price & Clinical Trials Insight 2025 - Product Thumbnail Image

Bevacizumab Biosimilar Market Opportunity, Sales, Price & Clinical Trials Insight 2025

  • Report
  • December 2020
  • 120 Pages
  • Global
From
Bevacizumab Biosimilars Global Market Report 2024 - Product Thumbnail Image

Bevacizumab Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024 - Product Thumbnail Image

Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Bevacizumab Biosimilar Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Bevacizumab Biosimilar Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type

  • Report
  • April 2023
  • 119 Pages
  • Global
From
Remicade Biosimilar Global Market Report 2024 - Product Thumbnail Image

Remicade Biosimilar Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Avastin (bevacizumab; Genentech/Roche/Chugai) Drug Overview 2019 - Product Thumbnail Image

Avastin (bevacizumab; Genentech/Roche/Chugai) Drug Overview 2019

  • Drug Pipelines
  • March 2019
  • 111 Pages
  • Global
Adalimumab Biosimilar Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Adalimumab Biosimilar Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • October 2023
  • 150 Pages
  • Global
From
Afinitor (everolimus; Novartis) Drug Overview 2019 - Product Thumbnail Image

Afinitor (everolimus; Novartis) Drug Overview 2019

  • Report
  • March 2019
  • 30 Pages
  • Global
Avastin Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Avastin Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 92 Pages
  • Global
From
Adalimumab Biosimilar Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Adalimumab Biosimilar Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 95 Pages
  • Global
From
Adalimumab (Humira) Biosimilars Pipeline Review - Product Thumbnail Image

Adalimumab (Humira) Biosimilars Pipeline Review

  • Report
  • April 2024
  • Global
From
Global Axial Spondyloarthritis Market by Type (Ankylosing Spondylitis (AS), Non-Radiographic Axial Spondyloarthritis (nr-axSpA))), Drug Class (Anti-Rheumatic Drugs, Glucocorticoids, Non-steroidal anti-inflammatory Drugs (NSAIDs)), End User - Forecast 2024-2030 - Product Thumbnail Image

Global Axial Spondyloarthritis Market by Type (Ankylosing Spondylitis (AS), Non-Radiographic Axial Spondyloarthritis (nr-axSpA))), Drug Class (Anti-Rheumatic Drugs, Glucocorticoids, Non-steroidal anti-inflammatory Drugs (NSAIDs)), End User - Forecast 2024-2030

  • Report
  • March 2024
  • 180 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Humira Drug Global Market Report 2024 - Product Thumbnail Image

Humira Drug Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global Adalimumab Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Global Adalimumab Drugs Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 140 Pages
  • Global
From
Global Drug Adherence Market: Focus on Smart Delivery Devices (Smart Inhalers, Injectors, Wearable Injectors, Pills) and Smart Accessories (Medication Dispensers, Pill Bottles / Boxes, Blister Packs) - Product Thumbnail Image

Global Drug Adherence Market: Focus on Smart Delivery Devices (Smart Inhalers, Injectors, Wearable Injectors, Pills) and Smart Accessories (Medication Dispensers, Pill Bottles / Boxes, Blister Packs)

  • Report
  • October 2018
  • 450 Pages
  • Global
From
Etanercept Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Etanercept Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 102 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Loading Indicator